Intravitreal Fluocinolone Acetonide Implant (ILUVIEN?) for the Treatment of Retinal Conditions. A Review of Clinical Studies

被引：7

作者：

Mushtaq, Yusuf ^{[1
,2
]}

Mushtaq, Maryam M. ^{[3
]}

Gatzioufas, Zisis ^{[4
,5
]}

Ripa, Matteo ^{[6
]}

Motta, Lorenzo ^{[7
,9
]}

Panos, Georgios D. ^{[1
,2
,8
]}

机构：

[1] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Ophthalmol, Nottingham, England

[2] Univ Nottingham, Sch Med, Nottingham, England

[3] Luton & Dunstable Univ Hosp NHS Trust, Dept Acute Med, Luton, England

[4] Basel Univ Hosp, Dept Ophthalmol, Basel, Switzerland

[5] Univ Basel, Sch Med, Basel, Switzerland

[6] Fdn Policlin Univ A Gemelli IRCCS, Ophthalmol Unit, Rome, Italy

[7] East Kent Hosp Univ NHS Fdn Trust, William Harvey Hosp, Dept Ophthalmol, Canterbury, Kent, England

[8] Queens Med Ctr, Dept Ophthalmol, Derby Rd, Nottingham NG7 2UH, England

[9] William Harvey Hosp, Dept Ophthalmol, Kennington Rd, Ashford TN24 0LZ, Kent, England

来源：

DRUG DESIGN DEVELOPMENT AND THERAPY | 2023年 / 17卷

关键词：

Iluvien; steroid implant; diabetic macular oedema; intravitreal implant; posterior uveitis; retinal vein occlusion; DIABETIC MACULAR EDEMA; LONG-TERM-BENEFIT; SUSTAINED-DELIVERY; NONINFECTIOUS INTERMEDIATE; AVAILABLE THERAPIES; VITREOUS INSERTS; EFFICACY; SAFETY; INJECTION; EYES;

D O I：

10.2147/DDDT.S403259

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Fluocinolone acetonide (FAc) intravitreal implant (Iluvien (R)) is a corticosteroid implant indicated for the treatment of diabetic macular oedema (DMO) in patients who have previously received conventional treatment without good response, non- infectious posterior uveitis, and as an off-label treatment of the macular oedema secondary to retinal vein occlusion. FAc is a non -biodegradable 0.19 mg intravitreal implant which is designed to release FAc over 3 years at a rate of approximately 0.2 mcg per day. The aim of this review is to describe the special pharmacological properties of Iluvien and display the outcomes of the most important clinical trials and real-world studies regarding its efficacy and safety for the management of the above retinal disorders.

引用

页码：961 / 975

页数：15

共 50 条

[31] Anterior Chamber Migration of Fluocinolone Acetonide Intravitreal Implant
Rishi, Pukhraj
Majumder, Parthopratim Dutta
Biswas, Jyotirmay
JAMA OPHTHALMOLOGY, 2019, 137 (09)
[32] Treatment of Refractory Diabetic Macular Edema with Intravitreal Injection of a Fluocinolone Acetonide Implant
Rubino, Shaina M.
Komanski, Chris Bligh
John, Vishak J.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[33] A Novel Technique for Repositioning of a Migrated ILUVIEN® (Fluocinolone Acetonide) Implant into the Anterior Chamber
El-Ghrably I.A.
Saad A.
Dinah C.
Ophthalmology and Therapy, 2015, 4 (2) : 129 - 133
[34] Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy
Mário Lima-Fontes
Mariana Leuzinger-Dias
Ricardo Barros-Pereira
Vítor Fernandes
Manuel Falcão
Fernando Falcão-Reis
Amândio Rocha-Sousa
Pedro Alves-Faria
Ophthalmology and Therapy, 2023, 12 : 377 - 388
[35] Fluocinolone acetonide intravitreal implant 0.19mg (ILUVIEN®) Vs Intravenous immunoglobulin (IvIg) in Cancer associated retinopathy
Abdulla, Didar
Taylor, Simon Richard
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
[36] Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy
Lima-Fontes, Mario
Leuzinger-Dias, Mariana
Barros-Pereira, Ricardo
Fernandes, Vitor
Falcao, Manuel
Falcao-Reis, Fernando
Rocha-Sousa, Amandio
Alves-Faria, Pedro
OPHTHALMOLOGY AND THERAPY, 2023, 12 (01) : 377 - 388
[37] Novel intravitreal fluocinolone acetonide implant in the treatment of chronic noninfectious posterior uveitis
Callanan, David G.
EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (01) : 33 - 44
[38] The outcome of chronic diabetic macular oedema in patients treated with intravitreal Fluocinolone acetonide (Iluvien)
El-Ghrably, Ibraheem
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[39] Challenging Clinical Cases - A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)
Pessoa, Bernardete
Melo-Beirao, Joao
Meireles, Angelina
Meneres, Pedro
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2020, 13 : 437 - 448
[40] Safety and efficacy of fluocinolone acetonide intravitreal implant (Iluvien®) in patients with chronic diabetic macular edema in a real-life setting
Santos, Monica
Campos, Antonio
Neves, Arminda
Alfaiate, Pedro
Pereira, Joana
Castro e Sousa, Joao Paulo
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)

← 1 2 3 4 5 →